Results 211 to 220 of about 351,954 (346)

Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description [PDF]

, 2019
Blozik, Eva, Eichler, Klaus, Rapold, Ronald, Reich, Oliver, Wieser, Simon   +4 more
core   +1 more source

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma [PDF]

, 2017
Maximilian Merz, Anna Jauch, Thomas Hielscher, Tilmann Bochtler, Stefan Schönland, Anja Seckinger, Dirk Hose, Uta Bertsch, Kai Neben, Marc S. Raab, Jens Hillengaß, Hans Salwender, Igor Wolfgang Blau, Hans‐Walter Lindemann, Ingo Schmidt‐Wolf, Christof Scheid, Mathias Haenel, Katja Weisel, Hartmut Goldschmidt   +18 more
openalex   +1 more source

Burden of haematological malignancies among children, adolescents and young adults: Global and high‐income region insights from the GBD 2021 study

British Journal of Haematology, EarlyView.
Summary This study provides a comprehensive assessment of haematological malignancies among children, adolescents and young adults aged 0–24 years, using data from the Global Burden of Disease 2021 across 204 countries from 1990 to 2021. We found that global incidence and prevalence remained relatively stable, with approximately 150 000 new cases and ...
Shujuan Xu, Baihua Yang, Xinxin Liu, Zhenshu Xu, Ping Weng   +4 more
wiley   +1 more source

Bone marrow angiogenesis in multiple myeloma: effect of therapy [PDF]

, 2002
Shaji Kumar, Rafaël Fonseca, Angela Dispenzieri, Martha Q. Lacy, John A. Lust, Thomas E. Witzig, Morie A. Gertz, Robert A. Kyle, Philip R. Greipp, S. Vincent Rajkumar   +9 more
openalex   +1 more source

The importance of assessing the fitness of older patients with newly diagnosed diffuse large B‐cell lymphoma and classic Hodgkin lymphoma

British Journal of Haematology, EarlyView.
Summary Several tools have been developed to provide prognostic indicators that are more accurate than chronological age alone because choosing the best treatment for older lymphoma patients is challenging. For older patients with diffuse large B‐cell lymphoma (DLBCL), one of these prognostic indicators is patient fitness; its definition has been ...
Vittorio Ruggero Zilioli, Alessandra Tucci, Michele Spina, Francesco Merli, Annalisa Arcari, on behalf of the Elderly Lymphoma Committee of the Fondazione Italiana Linfomi   +5 more
wiley   +1 more source

The Role of CELMoD Agents in Multiple Myeloma. [PDF]

Onco Targets Ther
van de Donk NWCJ, Bahlis NJ, Pawlyn C, Gay F, Mateos MV, Weisel K, Lonial S, Richardson PG.   +7 more
europepmc   +1 more source

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab [PDF]

, 2016
Hermann Einsele, Martin Schreder
openalex   +1 more source

MULTIPLE MYELOMA [PDF]

BMJ, 1907
J R, Charles, H H, Sanguinetti
openaire   +2 more sources

Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review

British Journal of Haematology, EarlyView.
This systematic review of 55 trials reveals significant inconsistency in defining transplant ineligibility for multiple myeloma. Arbitrary age cut‐offs predominantly drive exclusion, while validated frailty tools and specific comorbidities are frequently underutilized.
Karun Neupane, Mitch Singstock, Darshi Shah, Riyasha Dahal, Hira Mian, Febe Smith, Rajshekhar Chakraborty, Samer Al Hadidi, Maria Mainou, Ariel Grajales‐Cruz, Syeda Mahrukh Hussnain Naqvi, Kenneth H. Shain, Aaron Goodman, Luciano J. Costa, Muzaffar Qazilbash, Ghulam Rehman Mohyuddin   +15 more
wiley   +1 more source

Isolated Non-Secretory Extramedullary Relapse of Multiple Myeloma Responded Completely to Localized Radiotherapy

Danny Dawd, Shiv Kapur, Rouslan Kotchetkov   +2 more
openalex   +1 more source